跳至主要内容
临床试验/IRCT20221127056631N1
IRCT20221127056631N1招募中3 期

Comparing the neuroprotective effect of Brimonidine and placebo on visual indices in optic neuritis patients

Zahedan University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 45 years(—)
性别
All

入选标准

  • Informed and free consent to participate in the study
  • Acute optic neuritis
  • The age range of patients is 18 to 45 years
  • Spherical equivalent refractive error of three diopters of myopia to one and a half diopters of hyperopia

排除标准

  • History of optic neuritis in another normal eye
  • Use or history of using drugs affecting the immune system
  • History of any type of retinal surgery
  • History of optic disc swelling in each eye
  • Having amblyopia in one or both eyes
  • Diabetic retinopathy or any type of maculopathy
  • Color blindness

研究者

发起方
Zahedan University of Medical Sciences

相似试验